Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03313830 · ClinicalTrials.gov registry record · NA

Effect of Whey Protein Hydrolysate on Human Muscle Protein Synthesis

A NA study, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT03313830 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 11 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03313830, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

Muscle protein synthesis can be stimulated by ingestion of protein sources, such as whey, casein or soy. Protein supplementation can be useful to restore protein turnover after exercise but also to preserve skeletal muscle mass and function in aging adults. Ingestion of large doses of essential amino acids (EAA) or certain protein supplements may be an effective strategy to induce muscle protein synthesis. However, in many cases, it may not be practical or feasible to consume a large volume of amino acids or protein required for an effective response by muscle. Several evidences show how reduced strength and muscle mass, even in early life, are predictors of early mortality which explicit the importance of developing more effective methods to improve muscle quality. Therefore, identifying the better sources of protein that have higher anabolic potency is of high significance. The goal of this study is to determine the anabolic potency and efficacy of a new and novel Whey Protein Hydrolysate mixture (WPH) on skeletal muscle protein synthesis in healthy young subjects (age 20-35 yr). Previous studies on rats indicate WPH induces significant increases in muscle protein synthesis compared with carbohydrates or whey-amino acid mixture. WPH contains mostly peptides, which have physiological effects and could be absorbed more rapidly. Preliminary data from preclinical study has also demonstrated that WPH can stimulate muscle protein synthesis at lower doses compared with intact whey proteins. Thus, WPH could be absorbed more rapidly and may maximally stimulate muscle protein synthesis. Although there is substantial data on the individual effects of BCCA and intact protein such as whey, there have been no clinical investigations that have explored the efficacy of WPH for stimulating muscle protein synthesis in humans. Therefore, the investigators propose that WPH will increase muscle protein synthesis. They will compare the response of WHP to the response of WHEY when eq

Interventions

  • DIETARY_SUPPLEMENT Whey Protein Hydrolysate (WPH)
  • DIETARY_SUPPLEMENT Intact Whey Protein (WHEY)

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2017-10-07
Est. Completion 2020-11-06
Phase NA

What the Registry Record Tells You About NCT03313830

The ClinicalTrials.gov registry entry for NCT03313830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Whey Protein Hydrolysate (WPH) is the first listed.

NCT03313830 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03313830 about?

NCT03313830 is a clinical study titled "Effect of Whey Protein Hydrolysate on Human Muscle Protein Synthesis". Muscle protein synthesis can be stimulated by ingestion of protein sources, such as whey, casein or soy. Protein supplementation can be useful to restore protein turnover after exercise but also to preserve skeletal muscle mass and function in aging adults. Ingestion of large doses of essential amin...

What is the current status of trial NCT03313830?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2017-10-07. Estimated completion is 2020-11-06.

What interventions are being tested in trial NCT03313830?

The interventions under investigation include: Whey Protein Hydrolysate (WPH) (DIETARY_SUPPLEMENT), Intact Whey Protein (WHEY) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03313830?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.